Sernova has appointed a high caliber executive to its board of directors.
Dr. Mohammad Azab, MB ChB, MSc, MBA, has more than 30 years of experience in clinical research as well as corporate leadership and has led the global development of several drugs currently approved in oncology and other therapeutic areas.
He also currently sits on the board of directors of NASDAQ-listed companies Xenon Pharmaceuticals Inc. (XENE) and Durect Corporation (DRRX).
Source: https://ceo.ca/@newsfile/mustgrow-investor-webcast-today-tuesday-may-4th-at
Submitted May 05, 2021 at 07:10AM by mantegarvitrow5zv https://ift.tt/3nNfyYB
